当社は、数百に及ぶ特許化合物に対する測定法の開発及びバリデーションを行うことで、多くの製薬会社とパートナーシップを築いてまいりました。現在当社では、一連のバリデートされた測定法を構築しておりますので、御社の要望に沿った測定法のリクエストをお知らせください。
現在有効なバリデートされた非特許化合物の測定法は以下の通りです::
| List of Validated Assays | |||||
|---|---|---|---|---|---|
| ALL | A-F | G-L | M-R | S-Z | |
| COMPOUND | MATRIX | CALIBRATION RANGE | Anti-Coag | LTMS | TEMP |
|---|---|---|---|---|---|
| Maraviroc | Human Plasma | 1.00 - 1,000 ng/mL | K2EDTA | 180 | -20 |
| Mefenamic acid | Human Plasma | 50.0 - 5,000 ng/mL | K3EDTA | 119 | -70 |
| Memantine | Human Plasma | 0.100 - 100 ng/mL | K3EDTA | 429 | -20 |
| Mesalamine | Human Plasma | 2.00 to 1000 ng/mL | |||
| Metformin | Human Plasma | 5.00 - 5,000 ng/mL | K3EDTA | 56 days | -70 |
| R,S-Methadone | Human Plasma | 5.00 - 1,000 ng/mL | K3EDTA | 240 | -20 |
| Methotrexate / 7-Hydroxymethotrexate | Human Plasma | 1.00 - 500 ng/mL | NaEDTA | 527 | -20 |
| Methotrexate / 7-Hydroxymethotrexate | Human Plasma | 1.00 - 500 ng/mL | K2EDTA | 59 | -20 |
| Methotrexate / 7-Hydroxymethotrexate | Human Plasma | 1.00 - 500 ng/mL | K2EDTA | 50 | -70 |
| Methotrexate / 7-Hydroxymethotrexate | Human Urine | 1,000 - 50,000 ng/mL 50.0 - 2,500 ng/mL |
None | 89 | -20 |
| 1-Methyluric acid | Human Urine | 2,500 - 20,000 ng/mL | None | 131 | -20 |
| 1-Methyluric acid | Human Urine | 2,500 - 20,000 ng/mL | None | 131 | -70 |
| 1-Methylxanthine / 1,7-Dimethyluric acid | Human Urine | 500 - 20,000 ng/mL | None | 21 | -20 |
| 1-Methylxanthine / 1,7-Dimethyluric acid | Human Urine | 500 - 50,000 ng/mL | None | 21 | -20 |
| Metoprolol | Human Plasma | 0.500 - 250 ng/mL | Heparin/EDTA | 121 | -20,-70 |
| Midazolam / 1-Hydroxymidazolam | Human Plasma | 0.100 - 10.0 ng/mL | K2EDTA | 1093 | -20 |
| Midazolam / 1-Hydroxymidazolam / 4-Hydroxymidazolam |
Human Plasma | 0.100 - 50.0 ng/mL | K2EDTA | 117 | -20 |
| Moexipril / Hydrochlorothiazide | Human Plasma | 1.00 - 200 ng/mL | K2EDTA | 36 | -70 |
| Morphine / Morphine-6-glucuronide | Human Plasma | 0.500 - 100 ng/mL 2.5 - 500 ng/ml |
K2EDTA | 462 | -20 |
| Morphine / Morphine-3-glucuronide / Morphine-6-glucuronide | Human Plasma | 0.500 - 50.0 ng/mL 10.0 - 1,000 ng/mL 1.00 - 100 ng/mL |
|||
| Moxifloxacin | Human Plasma | 25.00 - 5,000 ng/mL | K2EDTA | 94 | -20 |
| Moxifloxacin | Human Plasma | 25.00 - 5,000 ng/mL | NaHep | 175 | -20 |
| Moxifloxacin | Human Plasma | 25.00 - 5,000 ng/mL | Lithium Heparin | 30 days | -70,-20 |
| Naltrexone / Naltrexol | Human Plasma | 20.0 - 2,000 pg/mL 0.500 - 50.0 ng/mL |
K2EDTA | 174 | -70 |
| Naltrexone / Naltrexol | Human Plasma | 4.00 - 4,000 pg/mL 0.250 - 250.0 pg/mL |
K2EDTA | 35 | -20 |
| Nelfinavir | Human Plasma | 1.00 - 1,000 ng/mL | K3EDTA | 100 | -20 |
| Nicotine/Cotinine | Human Plasma | 1.00 - 500 ng/mL 2.00 - 1,000 ng/mL |
EDTA | 184,~481 | -20,-70 |
| Nifedipine | Human Plasma | 1.00 - 250 ng/mL | K2EDTA | 277 | -20 |
| Nilotinib | Human Plasma | 5.00 - 2,000 ng/mL | K2EDTA | 102 | -20 |
| Nisoldipine | Human Plasma | 50.0 - 10,000 pg/mL | K2EDTA | 288 | -20 |
| Octreotide | Human Plasma | 50.0 - 20,000 pg/mL | |||
| Olanzapine | Human Plasma | 0.400 - 100 nM | K2EDTA | 234 | -20 |
| Omeprazole / 5-Hydroxyomeprazole | Human Plasma | 10.0 - 1,000 ng/mL | K3EDTA | 141 | -20 |
| Oxycodone | Human Plasma | 0.200 - 100 ng/mL | EDTA | 97 | -20 |
| Oxymorphone | Human Plasma | 0.0500 - 25.0 ng/mL | EDTA | 97 | -20 |
| Paclitaxel | Human Plasma | 10.0 - 2,000 ng/mL | K3EDTA | 433 | -20 |
| Paclitaxel | Human Plasma | 10.0 - 5,000 ng/mL | K2EDTA | 164 | -20,-70 |
| Paliperidone (9-Hydroxy Risperidone) | Human Plasma | 0.100 - 100 nM | |||
| Pramipexole | Human Plasma | 50.0 - 5,000 pg/mL | K3EDTA | 35 | -20 |
| Pregabalin | Human Plasma | 50.0 - 20,000 ng/mL | K2EDTA | 538 | -20 |
| Quetiapine | Human Plasma | 0.500 - 2,000 ng/mL | K2EDTA | 194,3 | -20,-70 |
| Raltegravir | Human Plasma | 1.00 - 1,000 ng/mL | |||
| Ramelteon | Human Plasma | 50.0 - 8,000 pg/mL | K2EDTA | 95 | -20 |
| Ranolazine | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | Pending | -20,-70 |
| Ribavarin | Human Plasma | 5.00 - 5,000 ng/mL | K2EDTA | 191 | -20,-70 |
| Rifaximin | Human Plasma | 0.100 - 10.0 ng/mL | K2EDTA | 448 | -20 |
| Riluzole | Human Plasma | 5.00 - 2,000 ng/mL | K3EDTA | -20 | |
| Riluzole | Dried Blood Spot | 5.00 - 2,000 ng/mL | |||
| Risperidone / 9-Hydroxy Risperidone (Paliperidone) | Human Plasma | 0.400 - 100 nM | K2EDTA | 219 | -20 |
| Rosiglitazone | Human Plasma | 1.00 - 1,000 ng/mL | K2EDTA |